Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 6/2019

01-12-2019 | Metastasis | Case Report

Neuroendocrine carcinoma of the esophagus with an adenocarcinoma component

Authors: Yuki Kaneko, Shin Saito, Kazuya Takahashi, Rihito Kanamaru, Yoshinori Hosoya, Hironori Yamaguchi, Joji Kitayama, Toshiro Niki, Alan Kawarai Lefor, Naohiro Sata

Published in: Clinical Journal of Gastroenterology | Issue 6/2019

Login to get access

Abstract

A 68-year-old male was referred with dysphagia. Endoscopic findings showed circular stenosis with a protruding mass in the lower esophagus. Biopsy showed adenocarcinoma and there was no evidence of distant metastases. A subtotal esophagectomy was performed. The resected specimen revealed a mixed neuroendocrine carcinoma with adenocarcinoma. The adenocarcinoma component was on the surface of the tumor and the neuroendocrine component invaded the deeper portion. Immunohistochemically, the neuroendocrine carcinoma component stained positive for cytokeratin 7 and cytokeratin 20, suggesting that the neuroendocrine carcinoma originated from the adenocarcinoma. The adenocarcinoma component stained positive for MUC2, which suggests that the adenocarcinoma component originated from Barrett’s epithelium. Taken together, the neuroendocrine carcinoma may have originated from Barrett’s epithelium. A metastasis to the liver was found 2 months after the surgical resection. Chemotherapy was administered, but there was no response. Most esophageal neuroendocrine carcinomas are accompanied by adenocarcinoma or squamous cell components, suggesting that these carcinomas originate from pluripotent cells in squamous or Barrett’s epithelium. Appropriate chemotherapy for these lesions should be considered based on the cell of origin.
Literature
1.
go back to reference Kitajima T, Kaida S, Lee S, et al. Mixed adeno (neuro) endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus. World J Surg Oncol. 2013;11:218.CrossRef Kitajima T, Kaida S, Lee S, et al. Mixed adeno (neuro) endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus. World J Surg Oncol. 2013;11:218.CrossRef
2.
go back to reference Egashira A, Morita M, Kumagai R, et al. Neuroendocrine carcinoma of the esophagus: clinicopathological and immunohistochemical features of 14 cases. PLoS One. 2017;12:e0173501.CrossRef Egashira A, Morita M, Kumagai R, et al. Neuroendocrine carcinoma of the esophagus: clinicopathological and immunohistochemical features of 14 cases. PLoS One. 2017;12:e0173501.CrossRef
3.
go back to reference Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. International Agency for Research on Cancer. Lyon: IARC Press; 2010. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. International Agency for Research on Cancer. Lyon: IARC Press; 2010.
4.
go back to reference Deng HY, Ni PZ, Wang YC, et al. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250–6.CrossRef Deng HY, Ni PZ, Wang YC, et al. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250–6.CrossRef
5.
go back to reference Kadhim MM, Jespersen ML, Pilegaard HK, et al. Mixed adenoneuroendocrine carcinoma is a rare but important tumour found in the oesophagus. Case Rep Gastrointest Med. 2016;2016:9542687.PubMedPubMedCentral Kadhim MM, Jespersen ML, Pilegaard HK, et al. Mixed adenoneuroendocrine carcinoma is a rare but important tumour found in the oesophagus. Case Rep Gastrointest Med. 2016;2016:9542687.PubMedPubMedCentral
6.
go back to reference Tustumi F, Takeda FR, Uema RH, et al. Primary neuroendocrine neoplasm of the esophagus—report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4–10.CrossRef Tustumi F, Takeda FR, Uema RH, et al. Primary neuroendocrine neoplasm of the esophagus—report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4–10.CrossRef
7.
go back to reference Xiao X, Wang S, Xia S, et al. Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung tumor. OncoTargets Therapy. 2015;8:2209–14.CrossRef Xiao X, Wang S, Xia S, et al. Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung tumor. OncoTargets Therapy. 2015;8:2209–14.CrossRef
8.
go back to reference Asayama M, Fuse N, Yoshino T, et al. Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases. Cancer Chemother Pharmacol. 2011;68:1325–30.CrossRef Asayama M, Fuse N, Yoshino T, et al. Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases. Cancer Chemother Pharmacol. 2011;68:1325–30.CrossRef
9.
go back to reference Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32:1404–11.CrossRef Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32:1404–11.CrossRef
10.
go back to reference Cary NR, Barron DJ, McGoldrick JP, et al. Combined oesophageal adenocarcinoma and carcinoid in Barrett’s oesophagitis: potential role of enterochromaffin-like cells in oesophageal malignancy. Thorax. 1993;48:404–5.CrossRef Cary NR, Barron DJ, McGoldrick JP, et al. Combined oesophageal adenocarcinoma and carcinoid in Barrett’s oesophagitis: potential role of enterochromaffin-like cells in oesophageal malignancy. Thorax. 1993;48:404–5.CrossRef
11.
go back to reference McIntire MG, Soucy G, Vaughan TL, et al. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol. 2011;35:1007–13.CrossRef McIntire MG, Soucy G, Vaughan TL, et al. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol. 2011;35:1007–13.CrossRef
12.
go back to reference Turkmen IC, Bassullu N, Uraz S, et al. CDX2, COX2 and MUC2 expressions in Barrett’s esophagus: can they be useful in determination of the dysplasia? Turk patoloji dergisi. 2012;28:251–8.PubMed Turkmen IC, Bassullu N, Uraz S, et al. CDX2, COX2 and MUC2 expressions in Barrett’s esophagus: can they be useful in determination of the dysplasia? Turk patoloji dergisi. 2012;28:251–8.PubMed
13.
go back to reference Saint Martin MC, Chejfec G. Barrett esophagus-associated small cell carcinoma. Arch Pathol Lab Med. 1999;123:1123.PubMed Saint Martin MC, Chejfec G. Barrett esophagus-associated small cell carcinoma. Arch Pathol Lab Med. 1999;123:1123.PubMed
14.
go back to reference Okuma HS, Iwasa S, Shoji H, et al. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus. Anticancer Res. 2014;34:5037–41.PubMed Okuma HS, Iwasa S, Shoji H, et al. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus. Anticancer Res. 2014;34:5037–41.PubMed
15.
go back to reference Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRef Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRef
16.
go back to reference Saif MW, Vethody C. Poorly differentiated neuroendocrine tumor of the esophagus with hypertrophic osteoarthropathy and brain metastasis: a success story. Cureus. 2016;8:646. Saif MW, Vethody C. Poorly differentiated neuroendocrine tumor of the esophagus with hypertrophic osteoarthropathy and brain metastasis: a success story. Cureus. 2016;8:646.
Metadata
Title
Neuroendocrine carcinoma of the esophagus with an adenocarcinoma component
Authors
Yuki Kaneko
Shin Saito
Kazuya Takahashi
Rihito Kanamaru
Yoshinori Hosoya
Hironori Yamaguchi
Joji Kitayama
Toshiro Niki
Alan Kawarai Lefor
Naohiro Sata
Publication date
01-12-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 6/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00995-7

Other articles of this Issue 6/2019

Clinical Journal of Gastroenterology 6/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.